Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA, EUROPE AND ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TEST TYPE LIFELINE CURVE (NORTH AMERCA)
2.8 TEST TYPE LIFELINE CURVE (EUROPE)
2.9 TEST TYPE LIFELINE CURVE (ASIA-PACIFIC)
2.1 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.11 DBMR MARKET POSITION GRID
2.12 MARKET TESTING TYPE COVERAGE GRID
2.13 VENDOR SHARE ANALYSIS
2.14 SECONDARY SOURCES
2.15 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
4.3 KEY STRATEGIC INITIATIVES
4.4 TREND ANALYSIS
4.4.1 TV (TRICHOMONAS VAGINALIS)
4.4.2 M. GEN (MYCOPLASMA GENITALIUM)
4.4.3 HIV
4.4.4 HBV, HCV (HEPATITIS B & C)
4.4.5 CMV (CYTOMEGALOVIRUS)
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 GROWING INCIDENCES OF SEXUALLY TRANSMITTED DISEASES
5.1.2 GROWING AWARENESS ABOUT STDS
5.1.3 RISE IN THE PREFERENCE FOR HOME CARE TESTING IN WOMEN SEXUAL WELLNESS
5.2 RESTRAINTS
5.2.1 HIGH COST ASSOCIATED WITH TESTING
5.2.2 STIGMA AND SOCIAL TABOOS A CHALLENGE
5.3 OPPORTUNITIES
5.3.1 INCREASING PRODUCT APPROVALS AND PRODUCT LAUNCHES FOR SEXUAL WELLNESS
5.3.2 THE INCREASING PRODUCTS APPROVALS AND THEIR LAUNCHES
5.4 CHALLENGES
5.4.1 LACK OF STANDARDIZATION, GUIDELINES, AND ETHICAL CONSIDERATIONS
5.4.2 LACK OF COMPREHENSIVE EDUCATION
6 NORTH AMERICA, EUROPE AND ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE
6.1 OVERVIEW
6.2 HUMAN PAPILLOMAVIRUS (HPV) TESTING
6.3 GENITAL HERPES
6.4 CERVICAL CANCER
6.4.1 PAP SMEAR TEST
6.4.2 OTHER DIAGNOSTIC TESTS
6.5 CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TEST
6.5.1 RAPID TEST KITS
6.5.2 SEROLOGY TESTS
6.5.3 DIRECT FLUORESCENT ANTIBODY TEST
6.5.4 OTHER TEST TYPES
6.6 HIV TEST
6.6.1 ANTIBODY TEST
6.6.2 NUCLEIC ACID TESTS (NATS)
6.6.3 OTHERS
6.7 HCV TEST
6.7.1 HCV ANTIBODY TESTING
6.7.2 HCV VIRAL LOAD TESTING
6.7.3 HCV GENOTYPING TESTING
6.7.4 BACTERIAL VAGINOSIS
6.8 TUBERCULOSIS
6.8.1 CULTURE BASED DIAGNOSIS
6.8.2 SPUTUM SPEAR MICROSCOPY
6.8.3 RAPID MOLECULAR DIAGNOSTICS
6.9 VIRAL COMPLICATIONS WITH TRANSPLANT
6.1 OTHERS
7 NORTH AMERICA, EUROPE AND ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET, BY TEST LOCATION
7.1 OVERVIEW
7.2 POINT-OF-CARE TESTING
7.2.1 HUMAN PAPILLOMAVIRUS (HPV) TESTING
7.2.2 GENITAL HERPES
7.2.3 CERVICAL CANCER
7.2.4 CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TEST
7.2.5 HIV TEST
7.2.6 HCV TEST
7.2.7 BACTERIAL VAGINOSIS
7.2.8 TUBERCULOSIS
7.2.9 VIRAL COMPLICATIONS WITH TRANSPLANT
7.2.10 OTHERS
7.3 SELF-COLLECTION/AT HOME TESTING
7.3.1 GENITAL HERPES
7.3.2 CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TEST
7.3.3 HUMAN PAPILLOMAVIRUS (HPV) TESTING
7.3.4 HIV TEST
7.3.5 HCV TEST
7.3.6 BACTERIAL VAGINOSIS
7.3.7 CERVICAL CANCER
7.3.8 TUBERCULOSIS
7.3.9 VIRAL COMPLICATIONS WITH TRANSPLANT
7.3.10 OTHERS
7.4 OVER-THE-COUNTER TESTING
7.4.1 CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TEST
7.4.2 HCV TEST
7.4.3 GENITAL HERPES
7.4.4 HUMAN PAPILLOMAVIRUS (HPV) TESTING
7.4.5 HIV TEST
7.4.6 BACTERIAL VAGINOSIS
7.4.7 CERVICAL CANCER
7.4.8 TUBERCULOSIS
7.4.9 VIRAL COMPLICATIONS WITH TRANSPLANT
7.4.10 OTHERS
7.5 OTHERS
8 NORTH AMERICA, EUROPE AND ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET, BY TECHNOLOGY
8.1 OVERVIEW
8.2 SEROLOGY
8.3 MOLECULAR
8.4 CULTURE/ISOLATION OF ORGANISM
8.5 OTHERS
9 NORTH AMERICA, EUROPE AND ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET, BY END USER
9.1 OVERVIEW
9.2 HOSPITALS
9.3 PUBLIC
9.4 PRIVATE
9.5 CLINICS
9.5.1 WOMEN HEALTHCARE CLINICS
9.5.2 GYNECOLOGY CLINICS
9.5.3 OTHERS
9.6 DIAGNOSTIC CENTERS
9.7 LABORATORIES
9.8 HOME CARE SETTING
9.9 OTHERS
10 NORTH AMERICA, EUROPE AND ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 OFFLINE
10.3 ONLINE
11 NORTH AMERICA, EUROPE AND ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET : BY REGION
11.1 NORTH AMERICA
11.1.1 U.S.
11.1.2 CANADA.
11.2 EUROPE
11.2.1 GERMANY
11.2.2 U.K.
11.2.3 FRANCE
11.3 ASIA-PACIFIC
11.3.1 HINA
11.3.2 JAPAN
11.3.3 AUSTRALIA
12 NORTH AMERICA, EUROPE AND ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET, COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
12.2 COMPANY SHARE ANALYSIS: EUROPE
12.3 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
13 SWOT ANALYSIS
14 NORTH AMERICA, EUROPE, ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET
14.1 HOLOGIC, INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 PRODUCT PORTFOLIO
14.1.4 RECENT DEVELOPMENT
14.2 CEPHEID. (SUBSIDARY OF DANAHER)
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 PRODUCT PORTFOLIO
14.2.4 RECENT DEVELOPMENT
14.3 F. HOFFMANN-LA ROCHE LTD.
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 PRODUCT PORTFOLIO
14.3.4 RECENT DEVELOPMENT
14.4 ABBOTT
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENT
14.5 BIO-RAD LABORATORIES, INC.
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 PRODUCT PORTFOLIO
14.5.4 RECENT DEVELOPMENT
14.6 ACCUQUIK TEST KITS. (ADVACARE PHARMA USA)
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENT
14.7 ARBOR VITA CORPORATION
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENT
14.8 BD.
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENTS
14.9 BIOMED DIAGNOSTICS, A DCN DX BRAND
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENT
14.1 BIOMÉRIEUX (2022)
14.10.1 COMPANY SNAPSHOT
14.10.2 REVENUE ANALYSIS
14.10.3 PRODUCT PORTFOLIO
14.10.4 RECENT DEVELOPMENT
14.11 CHEMBIO DIAGNOSTICS, INC. (2022)
14.11.1 COMPANY SNAPSHOT
14.11.2 REVENUE ANALYSIS
14.11.3 PRODUCT PORTFOLIO
14.11.4 RECENT DEVELOPMENT
14.12 ELITECH GROUP
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENT
14.13 JOYSBIO (TIANJIN) BIOTECHNOLOGY CO., LTD
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 ORASURE TECHNOLOGIES
14.14.1 COMPANY SNAPSHOT
14.14.2 REVENUE ANALYSIS
14.14.3 PRODUCT PORTFOLIO
14.14.4 RECENT DEVELOPMENT
14.15 QUIDEL CORPORATION
14.15.1 COMPANY SNAPSHOT
14.15.2 REVENUE ANALYSIS
14.15.3 PRODUCT PORTFOLIO
14.15.4 RECENT DEVELOPMENT
14.16 RANDOX LABORATORIES LTD.
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENT
14.17 SEKISUI DIAGNOSTICS (A PART OF SEKISUI CHEMICAL CO. LTD.)
14.17.1 COMPANY SNAPSHOT
14.17.2 REVENUE ANALYSIS
14.17.3 PRODUCT PORTFOLIO
14.17.4 RECENT DEVELOPMENT
14.18 TRINITY BIOTECH (2022)
14.18.1 COMPANY SNAPSHOT
14.18.2 REVENUE ANALYSIS
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
TABLE 1 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 2 EUROPE WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 3 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 4 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 5 EUROPE WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 6 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 7 NORTH AMERICA CERVICAL CANCER IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 8 EUROPE CERVICAL CANCER IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 9 ASIA-PACIFIC CERVICAL CANCER IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 10 NORTH AMERICA CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 11 EUROPE CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 12 ASIA-PACIFIC CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 13 NORTH AMERICA HIV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 14 EUROPE HIV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 15 ASIA-PACIFIC HIV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 16 NORTH AMERICA HCV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 17 EUROPE HCV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 18 ASIA-PACIFIC HCV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 19 NORTH AMERICA TUBERCULOSIS IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 20 EUROPE TUBERCULOSIS IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 21 ASIA-PACIFIC TUBERCULOSIS IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 22 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET, BY TEST LOCATION, 2021-2030 (USD MILLION)
TABLE 23 EUROPE WOMEN SEXUAL WELLNESS MARKET, BY TEST LOCATION, 2021-2030 (USD MILLION)
TABLE 24 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET, BY TEST LOCATION, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA POINT-OF-CARE TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 26 EUROPE POINT-OF-CARE TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 27 ASIA-PACIFIC POINT-OF-CARE TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 28 NORTH AMERICA SELF-COLLECTION/AT HOME TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 29 EUROPE SELF-COLLECTION/AT HOME TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 30 ASIA-PACIFIC SELF-COLLECTION/AT HOME TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 31 NORTH AMERICA OVER THE COUNTER TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 32 EUROPE OVER THE COUNTER TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 33 ASIA-PACIFIC OVER THE COUNTER TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 34 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 35 EUROPE WOMEN SEXUAL WELLNESS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 36 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 37 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 38 EUROPE WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 39 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 40 NORTH AMERICA HOSPITALS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 41 EUROPE HOSPITALS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 42 ASIA-PACIFIC HOSPITALS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 43 NORTH AMERICA CLINICS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 44 EUROPE CLINICS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 45 ASIA-PACIFIC CLINICS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 46 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 47 EUROPE WOMEN SEXUAL WELLNESS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 48 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 49 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 50 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 51 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 52 NORTH AMERICA CERVICAL CANCER IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 53 NORTH AMERICA CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 54 NORTH AMERICA HIV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 55 NORTH AMERICA HCV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 56 NORTH AMERICA TUBERCULOSIS IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 57 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET, BY TEST LOCATION, 2021-2030 (USD MILLION)
TABLE 58 NORTH AMERICA POINT-OF-CARE TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 59 NORTH AMERICA SELF-COLLECTION/AT HOME TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 60 NORTH AMERICA OVER THE COUNTER TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 61 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 62 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 63 NORTH AMERICA HOSPITALS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 64 NORTH AMERICA CLINICS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 65 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 66 U.S. WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 67 U.S. WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 ASP
TABLE 68 U.S. WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 69 U.S. CERVICAL CANCER IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 70 U.S. CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 71 U.S. HIV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 72 U.S. HCV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 73 U.S. TUBERCULOSIS IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 74 U.S. WOMEN SEXUAL WELLNESS MARKET, BY TEST LOCATION, 2021-2030 (USD MILLION)
TABLE 75 U.S. POINT-OF-CARE TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 76 U.S. SELF-COLLECTION/AT HOME TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 77 U.S. OVER THE COUNTER TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 78 U.S. WOMEN SEXUAL WELLNESS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 79 U.S. WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 80 U.S. HOSPITALS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 81 U.S. CLINICS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 82 U.S. WOMEN SEXUAL WELLNESS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 83 CANADA WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 84 CANADA WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 ASP
TABLE 85 CANADA WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 86 CANADA CERVICAL CANCER IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 87 CANADA CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 88 CANADA HIV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 89 CANADA HCV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 90 CANADA TUBERCULOSIS IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 91 CANADA WOMEN SEXUAL WELLNESS MARKET, BY TEST LOCATION, 2021-2030 (USD MILLION)
TABLE 92 CANADA POINT-OF-CARE TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 93 CANADA SELF-COLLECTION/AT HOME TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 94 CANADA OVER THE COUNTER TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 95 CANADA WOMEN SEXUAL WELLNESS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 96 CANADA WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 97 CANADA HOSPITALS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 98 CANADA CLINICS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 99 CANADA WOMEN SEXUAL WELLNESS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 100 EUROPE WOMEN SEXUAL WELLNESS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 101 EUROPE WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 102 EUROPE WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 103 EUROPE CERVICAL CANCER IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 104 EUROPE CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 105 EUROPE HIV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 106 EUROPE HCV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 107 EUROPE TUBERCULOSIS IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 108 EUROPE WOMEN SEXUAL WELLNESS MARKET, BY TEST LOCATION, 2021-2030 (USD MILLION)
TABLE 109 EUROPE POINT-OF-CARE TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 110 EUROPE SELF-COLLECTION/AT HOME TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 111 EUROPE OVER THE COUNTER TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 112 EUROPE WOMEN SEXUAL WELLNESS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 113 EUROPE WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 114 EUROPE HOSPITALS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 115 EUROPE CLINICS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 116 EUROPE WOMEN SEXUAL WELLNESS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 117 GERMANY WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 118 GERMANY WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 ASP
TABLE 119 GERMANY WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 120 GERMANY CERVICAL CANCER IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 121 GERMANY CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 122 GERMANY HIV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 123 GERMANY HCV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 124 GERMANY TUBERCULOSIS IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 125 GERMANY WOMEN SEXUAL WELLNESS MARKET, BY TEST LOCATION, 2021-2030 (USD MILLION)
TABLE 126 GERMANY POINT-OF-CARE TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 127 GERMANY SELF-COLLECTION/AT HOME TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 128 GERMANY OVER THE COUNTER TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 129 GERMANY WOMEN SEXUAL WELLNESS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 130 GERMANY WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 131 GERMANY HOSPITALS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 132 GERMANY CLINICS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 133 GERMANY WOMEN SEXUAL WELLNESS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 134 U.K. WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 135 U.K. WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 ASP
TABLE 136 U.K. WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 137 U.K. CERVICAL CANCER IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 138 U.K. CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 139 U.K. HIV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 140 U.K. HCV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 141 U.K. TUBERCULOSIS IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 142 U.K. WOMEN SEXUAL WELLNESS MARKET, BY TEST LOCATION, 2021-2030 (USD MILLION)
TABLE 143 U.K. POINT-OF-CARE TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 144 U.K. SELF-COLLECTION/AT HOME TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 145 U.K. OVER THE COUNTER TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 146 U.K. WOMEN SEXUAL WELLNESS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 147 U.K. WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 148 U.K. HOSPITALS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 149 U.K. CLINICS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 150 U.K. WOMEN SEXUAL WELLNESS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 151 FRANCE WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 152 FRANCE WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 ASP
TABLE 153 FRANCE WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 154 FRANCE CERVICAL CANCER IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 155 FRANCE CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 156 FRANCE HIV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 157 FRANCE HCV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 158 FRANCE TUBERCULOSIS IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 159 FRANCE WOMEN SEXUAL WELLNESS MARKET, BY TEST LOCATION, 2021-2030 (USD MILLION)
TABLE 160 FRANCE POINT-OF-CARE TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 161 FRANCE SELF-COLLECTION/AT HOME TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 162 FRANCE OVER THE COUNTER TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 163 FRANCE WOMEN SEXUAL WELLNESS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 164 FRANCE WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 165 FRANCE HOSPITALS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 166 FRANCE CLINICS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 167 FRANCE WOMEN SEXUAL WELLNESS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 168 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 169 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 170 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 171 ASIA-PACIFIC CERVICAL CANCER IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 172 ASIA-PACIFIC CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 173 ASIA-PACIFIC HIV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 174 ASIA-PACIFIC HCV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 175 ASIA-PACIFIC TUBERCULOSIS IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 176 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET, BY TEST LOCATION, 2021-2030 (USD MILLION)
TABLE 177 ASIA-PACIFIC POINT-OF-CARE TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 178 ASIA-PACIFIC SELF-COLLECTION/AT HOME TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 179 ASIA-PACIFIC OVER THE COUNTER TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 180 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 181 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 182 ASIA-PACIFIC HOSPITALS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 183 ASIA-PACIFIC CLINICS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 184 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 185 CHINA WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 186 CHINA WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 ASP
TABLE 187 CHINA WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 188 CHINA CERVICAL CANCER IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 189 CHINA CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 190 CHINA HIV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 191 CHINA HCV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 192 CHINA TUBERCULOSIS IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 193 CHINA WOMEN SEXUAL WELLNESS MARKET, BY TEST LOCATION, 2021-2030 (USD MILLION)
TABLE 194 CHINA POINT-OF-CARE TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 195 CHINA SELF-COLLECTION/AT HOME TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 196 CHINA OVER THE COUNTER TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 197 CHINA WOMEN SEXUAL WELLNESS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 198 CHINA WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 199 CHINA HOSPITALS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 200 CHINA CLINICS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 201 CHINA WOMEN SEXUAL WELLNESS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 202 JAPAN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 203 JAPAN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 ASP
TABLE 204 JAPAN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 205 JAPAN CERVICAL CANCER IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 206 JAPAN CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 207 JAPAN HIV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 208 JAPAN HCV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 209 JAPAN TUBERCULOSIS IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 210 JAPAN WOMEN SEXUAL WELLNESS MARKET, BY TEST LOCATION, 2021-2030 (USD MILLION)
TABLE 211 JAPAN POINT-OF-CARE TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 212 JAPAN SELF-COLLECTION/AT HOME TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 213 JAPAN OVER THE COUNTER TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 214 JAPAN WOMEN SEXUAL WELLNESS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 215 JAPAN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 216 JAPAN HOSPITALS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 217 JAPAN CLINICS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 218 JAPAN WOMEN SEXUAL WELLNESS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 219 AUSTRALIA WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 220 AUSTRALIA WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 ASP
TABLE 221 AUSTRALIA WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 222 AUSTRALIA CERVICAL CANCER IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 223 AUSTRALIA CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 224 AUSTRALIA HIV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 225 AUSTRALIA HCV TEST IN WOMEN SEXUAL WELLNESS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 226 AUSTRALIA TUBERCULOSIS IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 227 AUSTRALIA WOMEN SEXUAL WELLNESS MARKET, BY TEST LOCATION, 2021-2030 (USD MILLION)
TABLE 228 AUSTRALIA POINT-OF-CARE TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 229 AUSTRALIA SELF-COLLECTION/AT HOME TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 230 AUSTRALIA OVER THE COUNTER TESTING IN WOMEN SEXUAL WELLNESS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 231 AUSTRALIA WOMEN SEXUAL WELLNESS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 232 AUSTRALIA WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 233 AUSTRALIA HOSPITALS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 234 AUSTRALIA CLINICS IN WOMEN SEXUAL WELLNESS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 235 AUSTRALIA WOMEN SEXUAL WELLNESS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
List of Figure
FIGURE 1 NORTH AMERICA, EUROPE AND ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA, EUROPE AND ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA, EUROPE AND ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE WOMEN SEXUAL WELLNESS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 6 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 7 NORTH AMERICA, EUROPE AND ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 8 NORTH AMERICA, EUROPE AND ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: DBMR MARKET POSITION GRID
FIGURE 10 EUROPE WOMEN SEXUAL WELLNESS MARKET: DBMR MARKET POSITION GRID
FIGURE 11 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: DBMR MARKET POSITION GRID
FIGURE 12 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: MARKET TESTING TYPE COVERAGE GRID
FIGURE 13 EUROPE WOMEN SEXUAL WELLNESS MARKET: MARKET TESTING TYPE COVERAGE GRID
FIGURE 14 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: MARKET TESTING TYPE COVERAGE GRID
FIGURE 15 NORTH AMERICA, EUROPE AND ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: VENDOR SHARE ANALYSIS
FIGURE 16 NORTH AMERICA, EUROPE AND ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: SEGMENTATION
FIGURE 17 GROWING INCIDENCES OF SEXUALLY TRANSMITTED DISEASES ARE EXPECTED TO DRIVE THE NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET IN THE FORECAST PERIOD
FIGURE 18 GROWING INCIDENCES OF SEXUALLY TRANSMITTED DISEASES ARE EXPECTED TO DRIVE THE EUROPE WOMEN SEXUAL WELLNESS MARKET IN THE FORECAST PERIOD
FIGURE 19 GROWING INCIDENCES OF SEXUALLY TRANSMITTED DISEASES ARE EXPECTED TO DRIVE THE ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET IN THE FORECAST PERIOD
FIGURE 20 THE HUMAN PAPILLOMAVIRUS (HPV) TESTING SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET IN 2023 & 2030
FIGURE 21 THE HUMAN PAPILLOMAVIRUS (HPV) TESTING SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE WOMEN SEXUAL WELLNESS MARKET IN 2023 & 2030
FIGURE 22 THE HUMAN PAPILLOMAVIRUS (HPV) TESTING SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET IN 2023 & 2030
FIGURE 23 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NA, EUROPE AND APAC WOMEN SEXUAL WELLNESS MARKET
FIGURE 24 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: BY TEST TYPE, 2022
FIGURE 25 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION)
FIGURE 26 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: BY TEST TYPE, CAGR (2023-2030)
FIGURE 27 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: BY TEST TYPE, LIFELINE CURVE
FIGURE 28 EUROPE WOMEN SEXUAL WELLNESS MARKET: BY TEST TYPE, 2022
FIGURE 29 EUROPE WOMEN SEXUAL WELLNESS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION)
FIGURE 30 EUROPE WOMEN SEXUAL WELLNESS MARKET: BY TEST TYPE, CAGR (2023-2030)
FIGURE 31 EUROPE WOMEN SEXUAL WELLNESS MARKET: BY TEST TYPE, LIFELINE CURVE
FIGURE 32 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: BY TEST TYPE, 2022
FIGURE 33 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION)
FIGURE 34 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: BY TEST TYPE, CAGR (2023-2030)
FIGURE 35 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: BY TEST TYPE, LIFELINE CURVE
FIGURE 36 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: BY TEST LOCATION, 2022
FIGURE 37 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: BY TEST LOCATION, 2023-2030 (USD MILLION)
FIGURE 38 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: BY TEST LOCATION, CAGR (2023-2030)
FIGURE 39 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: BY TEST LOCATION, LIFELINE CURVE
FIGURE 40 EUROPE WOMEN SEXUAL WELLNESS MARKET: BY TEST LOCATION, 2022
FIGURE 41 EUROPE WOMEN SEXUAL WELLNESS MARKET: BY TEST LOCATION, 2023-2030 (USD MILLION)
FIGURE 42 EUROPE WOMEN SEXUAL WELLNESS MARKET: BY TEST LOCATION, CAGR (2023-2030)
FIGURE 43 EUROPE WOMEN SEXUAL WELLNESS MARKET: BY TEST LOCATION, LIFELINE CURVE
FIGURE 44 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: BY TEST LOCATION, 2022
FIGURE 45 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: BY TEST LOCATION, 2023-2030 (USD MILLION)
FIGURE 46 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: BY TEST LOCATION, CAGR (2023-2030)
FIGURE 47 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: BY TEST LOCATION, LIFELINE CURVE
FIGURE 48 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: BY TECHNOLOGY, 2022
FIGURE 49 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION)
FIGURE 50 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: BY TECHNOLOGY, CAGR (2023-2030)
FIGURE 51 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 52 EUROPE WOMEN SEXUAL WELLNESS MARKET: BY TECHNOLOGY, 2022
FIGURE 53 EUROPE WOMEN SEXUAL WELLNESS MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION)
FIGURE 54 EUROPE WOMEN SEXUAL WELLNESS MARKET: BY TECHNOLOGY, CAGR (2023-2030)
FIGURE 55 EUROPE WOMEN SEXUAL WELLNESS MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 56 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: BY TECHNOLOGY, 2022
FIGURE 57 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION)
FIGURE 58 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: BY TECHNOLOGY, CAGR (2023-2030)
FIGURE 59 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 60 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: BY END USER, 2022
FIGURE 61 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 62 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 63 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: BY END USER, LIFELINE CURVE
FIGURE 64 EUROPE WOMEN SEXUAL WELLNESS MARKET: BY END USER, 2022
FIGURE 65 EUROPE WOMEN SEXUAL WELLNESS MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 66 EUROPE WOMEN SEXUAL WELLNESS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 67 EUROPE WOMEN SEXUAL WELLNESS MARKET: BY END USER, LIFELINE CURVE
FIGURE 68 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: BY END USER, 2022
FIGURE 69 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 70 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 71 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: BY END USER, LIFELINE CURVE
FIGURE 72 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 73 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 74 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 75 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 76 EUROPE WOMEN SEXUAL WELLNESS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 77 EUROPE WOMEN SEXUAL WELLNESS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 78 EUROPE WOMEN SEXUAL WELLNESS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 79 EUROPE WOMEN SEXUAL WELLNESS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 80 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 81 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 82 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 83 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 84 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: SNAPSHOT (2022)
FIGURE 85 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: BY COUNTRY (2022)
FIGURE 86 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 87 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 88 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: TEST TYPE (2023-2030)
FIGURE 89 EUROPE WOMEN SEXUAL WELLNESS MARKET: SNAPSHOT (2022)
FIGURE 90 EUROPE WOMEN SEXUAL WELLNESS MARKET: BY COUNTRY (2022)
FIGURE 91 EUROPE WOMEN SEXUAL WELLNESS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 92 EUROPE WOMEN SEXUAL WELLNESS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 93 EUROPE WOMEN SEXUAL WELLNESS MARKET: TEST TYPE (2023-2030)
FIGURE 94 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: SNAPSHOT (2022)
FIGURE 95 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: BY COUNTRY (2022)
FIGURE 96 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 97 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 98 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: TEST TYPE (2023-2030)
FIGURE 99 NORTH AMERICA WOMEN SEXUAL WELLNESS MARKET: COMPANY SHARE 2022 (%)
FIGURE 100 EUROPE WOMEN SEXUAL WELLNESS MARKET: COMPANY SHARE 2022 (%)
FIGURE 101 ASIA-PACIFIC WOMEN SEXUAL WELLNESS MARKET: COMPANY SHARE 2022 (%)
